Recent Finacing
Recent Raise
ATB Therapeutics develops biologics that integrate enzymatic and cytotoxic functions into targeted antibodies, using ATBioFarm platform for single‑step production of multi‑domain antibodies; advancing oncology and immunology with pilot manufacturing.
